Allarity Therapeutics Inc Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.35M To $3.2M
Allarity Therapeutics Inc Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.35M To $3.2M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.